Here’s a breakdown of the key information from the provided text:
Murickan’s Platform:
* What it is: A multimodal platform for use in settings like telemedicine and neonatal intensive care (specifically for retinopathy of prematurity monitoring).
* Key Features:
* Flexible and adaptable.
* Relies on existing imaging technology, making implementation relatively easy.
* Uses a federated learning framework for continuous betterment.
* Crucially, clinicians retain final decision-making authority.
Next Steps (according to Murickan):
* Real-world testing: Across diverse clinical sites (diffrent populations, ages, and environments).
* Prospective studies: To measure:
* clinic flow efficiency
* Time savings
* Reduction in missed/false diagnoses
* Building Trust & Integration: Essential for triumphant implementation in ophthalmology and hospital settings.
Contact Information:
* Tom Murickan: tomtmurickan@gmail.com
Disclosure:
* Murickan has no relevant financial disclosures.
additional Information:
* Published by: Primary Care Optometry News (via Healio)
* Healio AI: Healio is promoting its AI tool, allowing users to ask clinical questions and access a knowledge base including PubMed, trials, guidelines, and Healio’s news coverage.
